KYTX
Kyverna Therapeutics, Inc.Company with tickers: KYTX
CIK
1994702
CUSIP
501976104
Shares Outstanding
60,455,189
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-13 | Biddle Warner Weston | Director, Chief Executive Officer | Award | 350,000 |
| 2026-03-13 | Biddle Warner Weston | Director, Chief Executive Officer | Award | 58,000 |
| 2026-03-13 | GRASSO MARC | CFO, CBO | Award | 65,000 |
| 2026-03-13 | GRASSO MARC | CFO, CBO | Award | 10,000 |
| 2026-03-13 | GEHCHAN NAJI | See Remarks | Award | 18,000 |
| 2026-03-13 | GEHCHAN NAJI | See Remarks | Award | 105,000 |
| 2026-02-24 | Miller Andrew Craig | Director | Award | 42,945 |
| 2026-02-24 | Miller Andrew Craig | Director | Award | 11,006 |
| 2026-02-24 | Emany Sravan Kumar | Director | Award | 11,006 |
| 2026-02-24 | Emany Sravan Kumar | Director | Award | 42,945 |
| 2026-02-24 | Miller Andrew Craig | Director | Other | 0 |
| 2026-02-24 | Emany Sravan Kumar | Director | Other | 0 |
| 2026-02-09 | Pujols Mayobanex | Chief Technology Officer | Award | 300,000 |
| 2026-02-09 | Pujols Mayobanex | Chief Technology Officer | Other | 0 |
| 2026-01-12 | Shaw Christi | Director | Award | 30,000 |
| 2026-01-12 | Shaw Christi | Director | Award | 185,000 |
| 2025-12-18 | SEIDENBERG BETH C | Director | Other | 3,787,940 |
| 2025-12-18 | SEIDENBERG BETH C | Director | Buy | 133,333 |
| 2025-12-18 | Westlake BioPartners Opportunity Fund I, L.P. | 10% Owner | Other | 3,787,940 |
| 2025-12-18 | Westlake BioPartners Opportunity Fund I, L.P. | 10% Owner | Buy | 133,333 |
| 2025-12-15 | Walker Karen Marie | Chief Technology Officer | Convert | 23,998 |
| 2025-12-15 | Walker Karen Marie | Chief Technology Officer | Sell | 23,998 |
| 2025-12-15 | Walker Karen Marie | Chief Technology Officer | Convert | 23,998 |
| 2025-06-30 | GRASSO MARC | CFO, CBO | Award | 450,000 |
| 2025-06-30 | GRASSO MARC | CFO, CBO | Other | 0 |
| 2025-05-29 | Shaw Christi | Director | Award | 65,351 |
| 2025-05-29 | Shaw Christi | Director | Award | 16,634 |
| 2025-05-29 | SEIDENBERG BETH C | Director | Other | 3,787,940 |
| 2025-05-29 | SEIDENBERG BETH C | Director | Award | 65,351 |
| 2025-05-29 | SEIDENBERG BETH C | Director | Award | 16,634 |
| 2025-05-29 | SPIEGELMAN DANIEL K | Director | Award | 16,634 |
| 2025-05-29 | SPIEGELMAN DANIEL K | Director | Award | 65,351 |
| 2025-05-29 | Aktar Mert | Director | Award | 16,634 |
| 2025-05-29 | Aktar Mert | Director | Award | 65,351 |
| 2025-05-29 | CLARK IAN T | Director | Award | 16,634 |
| 2025-05-29 | CLARK IAN T | Director | Award | 65,351 |
| 2025-05-29 | Cohen Fred E | Director | Award | 16,634 |
| 2025-05-29 | Cohen Fred E | Director | Award | 65,351 |
| 2025-05-29 | Cohen Fred E | Director | Other | 4,523,924 |
| 2025-04-11 | Jones Ryan Alexander | Chief Financial Officer | Award | 12,000 |
| 2025-04-11 | Walker Karen Marie | Chief Technology Officer | Award | 13,000 |
| 2025-02-14 | Shaw Christi | Director | Award | 38,679 |
| 2025-01-22 | GEHCHAN NAJI | See Remarks | Award | 425,000 |
| 2025-01-22 | GEHCHAN NAJI | See Remarks | Other | 0 |
| 2024-10-21 | Aktar Mert | Director | Award | 87,741 |
| 2024-10-21 | Aktar Mert | Director | Other | 0 |
| 2024-09-16 | Biddle Warner Weston | Director, Chief Executive Officer | Award | 2,579,259 |
| 2024-09-16 | Biddle Warner Weston | Director, Chief Executive Officer | Other | 0 |
| 2024-09-16 | Shaw Christi | Director | Award | 66,592 |
| 2024-09-16 | Shaw Christi | Director | Other | 0 |
| 2024-06-06 | Walker Karen Marie | Chief Technology Officer | Convert | 9,636 |
| 2024-06-06 | Walker Karen Marie | Chief Technology Officer | Convert | 9,636 |
| 2024-05-28 | Jones Ryan Alexander | Chief Financial Officer | Convert | 10,870 |
| 2024-05-28 | Jones Ryan Alexander | Chief Financial Officer | Convert | 10,870 |
| 2024-04-11 | Biddle Warner Weston | Director, Chief Executive Officer | Award | 332,500 |
| 2024-04-11 | Jones Ryan Alexander | Chief Financial Officer | Award | 74,000 |
| 2024-04-11 | Walker Karen Marie | Chief Technology Officer | Award | 80,000 |
| 2024-02-12 | Vida Ventures, LLC | 10% Owner | Other | 7,356,162 |
| 2024-02-12 | Vida Ventures, LLC | 10% Owner | Other | 4,523,924 |
| 2024-02-12 | Vida Ventures, LLC | 10% Owner | Other | 8,830,901 |
| 2024-02-12 | Vida Ventures, LLC | 10% Owner | Buy | 252,553 |
| 2024-02-12 | Vida Ventures, LLC | 10% Owner | Other | 4,401,771 |
| 2024-02-12 | Cohen Fred E | Director | Other | 8,830,901 |
| 2024-02-12 | Cohen Fred E | Director | Other | 4,523,924 |
| 2024-02-12 | Cohen Fred E | Director | Other | 4,401,771 |
| 2024-02-12 | Cohen Fred E | Director | Other | 7,356,162 |
| 2024-02-12 | SEIDENBERG BETH C | Director | Other | 4,401,771 |
| 2024-02-12 | SEIDENBERG BETH C | Director | Other | 4,006,624 |
| 2024-02-12 | SEIDENBERG BETH C | Director | Other | 3,787,940 |
| 2024-02-12 | SEIDENBERG BETH C | Director | Other | 8,830,901 |
| 2024-02-12 | Westlake BioPartners Fund I, L.P. | 10% Owner | Other | 4,006,624 |
| 2024-02-12 | Westlake BioPartners Fund I, L.P. | 10% Owner | Other | 8,830,901 |
| 2024-02-12 | Westlake BioPartners Fund I, L.P. | 10% Owner | Other | 3,787,940 |
| 2024-02-12 | Westlake BioPartners Fund I, L.P. | 10% Owner | Other | 4,401,771 |
| 2024-02-12 | Northpond Ventures III GP, LLC | Insider | Other | 12,767,776 |
| 2024-02-12 | Northpond Ventures III GP, LLC | Insider | Other | 2,805,426 |
| 2024-02-12 | Northpond Ventures III GP, LLC | Insider | Buy | 450,000 |
| 2024-02-12 | GILEAD SCIENCES, INC. | 10% Owner | Other | 3,216,119 |
| 2024-02-12 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 910,000 |
| 2024-02-12 | GILEAD SCIENCES, INC. | 10% Owner | Other | 6,890,744 |
| 2024-02-12 | GILEAD SCIENCES, INC. | 10% Owner | Other | 7,746,139 |
| 2024-02-12 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Other | 2,713,868 |
| 2024-02-12 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Other | 12,351,087 |
| 2024-02-12 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Buy | 450,000 |
| 2024-02-07 | Liapis Stephen Constantine | Director | Other | 0 |
| 2024-02-07 | CLARK IAN T | Director | Other | 0 |
| 2024-02-07 | Jones Ryan Alexander | Chief Financial Officer | Other | 25,934 |
| 2024-02-07 | Jones Ryan Alexander | Chief Financial Officer | Other | 0 |
| 2024-02-07 | SEIDENBERG BETH C | Director | Other | 0 |
| 2024-02-07 | SEIDENBERG BETH C | Director | Other | 0 |
| 2024-02-07 | SEIDENBERG BETH C | Director | Other | 0 |
| 2024-02-07 | SEIDENBERG BETH C | Director | Other | 0 |
| 2024-02-07 | Westlake BioPartners Fund I, L.P. | 10% Owner | Other | 0 |
| 2024-02-07 | Westlake BioPartners Fund I, L.P. | 10% Owner | Other | 0 |
| 2024-02-07 | Westlake BioPartners Fund I, L.P. | 10% Owner | Other | 0 |
| 2024-02-07 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Other | 0 |
| 2024-02-07 | Liapis Stephen Constantine | Director | Other | 0 |
| 2024-02-07 | Borie Dominique Christian | See Remarks | Other | 0 |
| 2024-02-07 | Borie Dominique Christian | See Remarks | Other | 449,210 |
| 2024-02-07 | GILEAD SCIENCES, INC. | 10% Owner | Other | 0 |